Literature DB >> 25073919

A review on anticancer potential of bioactive heterocycle quinoline.

Obaid Afzal1, Suresh Kumar1, Md Rafi Haider1, Md Rahmat Ali1, Rajiv Kumar1, Manu Jaggi2, Sandhya Bawa3.   

Abstract

The advent of Camptothecin added a new dimension in the field anticancer drug development containing quinoline motif. Quinoline scaffold plays an important role in anticancer drug development as their derivatives have shown excellent results through different mechanism of action such as growth inhibitors by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. The anti-cancer potential of several of these derivatives have been demonstrated on various cancer cell lines. In this review we have compiled and discussed specifically the anticancer potential of quinoline derivatives, which could provide a low-height flying bird's eye view of the quinoline derived compounds to a medicinal chemist for a comprehensive and target oriented information for development of clinically viable anticancer drugs.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer; Drug development; Quinoline

Mesh:

Substances:

Year:  2014        PMID: 25073919     DOI: 10.1016/j.ejmech.2014.07.044

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  66 in total

1.  Crystal structures of 1-(4-chloro-phen-yl)-4-(4-methyl-phen-yl)-2,5-dioxo-1,2,5,6,7,8-hexa-hydro-quinoline-3-carb-oxy-lic acid and 4-(4-meth-oxy-phen-yl)-1-(4-methyl-phen-yl)-2,5-dioxo-1,2,5,6,7,8-hexa-hydro-quinoline-3-carbo-nitrile.

Authors:  Omyma A Abd Allah; Manpreet Kaur; Mehmet Akkurt; Shaaban K Mohamed; Asmaa H A Tamam; Sahar M I Elgarhy; Jerry P Jasinski
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-03-05

2.  Quinoline and naphthalene derivatives from Saccharopolyspora sp. YIM M13568.

Authors:  Mingwei Sun; Jinhuan Ou; Wenjun Li; Chunhua Lu
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

3.  Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor.

Authors:  Jia Liu; Dongwei Xue; Xingwang Zhu; Liu Yu; Minghuan Mao; Yili Liu
Journal:  Invest New Drugs       Date:  2019-06-10       Impact factor: 3.850

Review 4.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

5.  Heterobiaryl synthesis by contractive C-C coupling via P(V) intermediates.

Authors:  Michael C Hilton; Xuan Zhang; Benjamin T Boyle; Juan V Alegre-Requena; Robert S Paton; Andrew McNally
Journal:  Science       Date:  2018-11-16       Impact factor: 47.728

6.  Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators.

Authors:  Pablo Garnica; Ignacio Encío; Daniel Plano; Juan A Palop; Carmen Sanmartín
Journal:  ACS Med Chem Lett       Date:  2018-03-13       Impact factor: 4.345

7.  Small-molecule agonists of the RET receptor tyrosine kinase activate biased trophic signals that are influenced by the presence of GFRa1 co-receptors.

Authors:  Sean Jmaeff; Yulia Sidorova; Hinyu Nedev; Mart Saarma; H Uri Saragovi
Journal:  J Biol Chem       Date:  2020-04-03       Impact factor: 5.157

8.  8-Hydroxyquinoline Glycoconjugates: Modifications in the Linker Structure and Their Effect on the Cytotoxicity of the Obtained Compounds.

Authors:  Monika Krawczyk; Gabriela Pastuch-Gawołek; Aleksandra Pluta; Karol Erfurt; Adrian Domiński; Piotr Kurcok
Journal:  Molecules       Date:  2019-11-18       Impact factor: 4.411

9.  A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.

Authors:  Erik Abner; Mateusz Stoszko; Lei Zeng; Heng-Chang Chen; Andrea Izquierdo-Bouldstridge; Tsuyoshi Konuma; Eduard Zorita; Elisa Fanunza; Qiang Zhang; Tokameh Mahmoudi; Ming-Ming Zhou; Guillaume J Filion; Albert Jordan
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

10.  Copper(ii) complexes based on quinoline-derived Schiff-base ligands: synthesis, characterization, HSA/DNA binding ability, and anticancer activity.

Authors:  Kun Hu; Chensi Liu; Jingui Li; Fupei Liang
Journal:  Medchemcomm       Date:  2018-09-06       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.